Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative anti-inflammatory treatment for postoperative muscle weakness and fatigue in elderly elective abdominal surgery patients
2011-005534-19Phase 4Completed
- Sponsor
- Vrije Universiteit Brussel
- Start
- Dec 2011
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept, molsidomine and fenofibrate in muscle weakness, asthenia and inflammation (4 arms), sponsored by Vrije Universiteit Brussel. Primary endpoints: Maximal handgrip strength, Muscle fatigue resistance and 1 more. Started Dec 2011; status: completed.
02
Drugs
etanerceptmolsidominefenofibrate
03
Conditions
muscle weaknessastheniainflammation
Beyond the preview
Go deeper on 2011-005534-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005534-19.